Association of Circulating Biomarkers with Disease Severity in Rheumatoid Arthritis: A Cross-Sectional Study
Authors:
- Mahdiyeh Hedayati MoghadamMMMahdiyeh Hedayati Moghadam
- Ali KamaliAKAli Kamali
- Rasoul RaesiRRRasoul Raesi
- Najmeh AfsharpourNANajmeh Afsharpour
- Sajedeh MohsenbeigiSMSajedeh Mohsenbeigi
- Khajouei Nia SholehKSKhajouei Nia Sholeh
- Habibe VazirinasabHVHabibe Vazirinasab
- Yousef BaghcheghiYBYousef Baghcheghi
- Salman DaneshiSDSalman Daneshi
Open Access
- 16 March 2026
- journal article
- Published by Bentham Science Publishers Ltd. in The Open Public Health Journal
- Vol. 19 (1)
Abstract
Introduction: Rheumatoid arthritis is one of the most common autoimmune diseases and can be associated with serious limitations in patients' activities and lifestyles. This study aimed to investigate the associations between circulating biomarkers (including RF, CRP, anti-CCP, Hb, ESR, AST, and ALT) and disease severity in patients with rheumatoid arthritis. Methods: This cross-sectional study was conducted using the census method on 148 patients referred to a specialized rheumatology clinic in Jiroft, Iran, in 2022. Data were collected through interviews, physical examinations, and reviews of patients’ medical records. The data were entered into the DAS-28 (Disease Activity Score-28) software for analysis of disease activity. Statistical analysis was performed using SPSS version 26. Results: The mean age of the patients was 51.84 years, most of whom were women. Rheumatoid factor (RF) was positive in 91 patients (61.5%) and negative in 57 patients (38.5%). C-reactive protein (CRP) was positive in 67 patients (45.3%) and negative in 81 patients (54.7%). Anti-cyclic citrullinated peptide (anti-CCP) was positive in 81 patients (54.7%) and negative in 67 patients (45.3%). The Disease Activity Score-28 (DAS-28) results indicated that 79 patients (53.5%) were in remission, 15 patients (10.1%) had low disease activity, and 54 patients (36.5%) had moderate to high disease activity. Discussion: There was a significant association between disease severity and patients’ gender, CRP results, anti-CCP status, mean hemoglobin (Hb) levels, and mean erythrocyte sedimentation rate (ESR). Conclusion: The findings support the use of a multidisciplinary approach to disease management, incorporating both laboratory tests and clinical assessments.Keywords
This publication has 42 references indexed in Scilit:
- Comprehensive insights into rheumatoid arthritis: Pathophysiology, current therapies and herbal alternatives for effective disease managementPhytotherapy Research, 2024
- 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid ArthritisArthritis & Rheumatology, 2021
- Distinctive Clinical Characteristics and Outcome of ILD-Onset Rheumatoid Arthritis and ACPA-Positive ILD: a Longitudinal Cohort of 282 CasesClinical Reviews in Allergy & Immunology, 2020
- Disease activity and disability in women and men with early rheumatoid arthritis (RA): An 8‐year followup of a Swedish early RA projectArthritis Care & Research, 2012
- Mean platelet volume in patients with rheumatoid arthritis: the effect of anti-TNF-alpha therapyRheumatology International, 2010
- Perception of improvement in patients with rheumatoid arthritis varies with disease activity levels at baselineArthritis Care & Research, 2009
- The association of anti-CCP antibodies with disease activity in rheumatoid arthritisRheumatology International, 2008
- Does the Presence of Anti-CCP Autoantibodies and Their Serum Levels Influence the Severity and Activity in Rheumatoid Arthritis Patients?Clinical Reviews in Allergy & Immunology, 2007
- Osteoprotegerin and the receptor activator of NF-kappa B ligand in the serum and synovial fluid. A comparison of patients with longstanding rheumatoid arthritis and osteoarthritisRheumatology International, 2005
- Clinical Implications of the Osteoprotegerin/RANKL/RANK System for Bone and Vascular DiseasesJAMA, 2004